ArticleBreast cancer research and treatment2026

Risk of second non-breast primary cancer in Chinese breast cancer patients with germline BRCA1/2 pathogenic variants.

Jiaming Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.